BONUS: This Natural Compound Cuts Calories by 18% – The Most Promising Alternative to GLP-1 Drugs with Sarah Kennedy | Metabolic Health & Menopause

episode

Previously titled “BONUS: This Natural Compound Cuts Calories by 18% – The Most Promising Alternative to GLP-1 Drugs with Sarah Kennedy” — renamed by the publisher on Aug 3, 2026

Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+ not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+

Ep. 531 Your Heart’s Not Just Skipping Beats – The Shocking Truth About Palpitations in Women | Women's Cardiovascular Health with Dr. Sanjay Bhojraj 1h 3m · 20 Dec 2025

All episodes from Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+ →

Report any issue

Source

Recorded15 Sep 2025

Publisherfeeds.megaphone.fm

Handlerec:5885652

Show notes

Today, we have the next episode in our series of sponsored podcasts with highly vetted companies. I am delighted to connect with Sarah Kennedy, the founder and CEO of Calocurb, a revolutionary product for weight management that became commercialized after 15 years and $30 million of research from the New Zealand government. Calocurb currently sells in five international markets and continues to grow rapidly through channels and geographies. Sarah is a veterinarian by training and has held several senior executive positions in the agribusiness and food industries. In our conversation today, we explore the science behind Calocurb, the evolutionary mechanisms of satiety, and how Calocurb reduces caloric intake by 18%. We discuss endogenous GLP-1 drugs, highlighting how Calocurb’s mechanism of action differs, and examining current research on gender differences in GLP-1 secretion, including their impact on the menstrual cycle and intermittent fasting. Sarah also covers the four core tenets of Calocurb, shares upcoming research that excites her, and explains the key differences between Calocurb and other supplements, like berberine and chromium. This conversation is truly invaluable, so it's worth revisiting. I am excited about Calocurb’s potential to support a variety of needs, helping those looking to improve their hunger and satiety mechanisms, and assisting those taking GLP-1 medications who want to reduce their dosage and transition off GLP-1 medications without compromising the long-term results. IN THIS EPISODE, YOU WILL LEARN: How Calocurb began How Calocurb supports those on GLP-1s looking to lower their doses or taper off (in conjunction with their healthcare team) Sarah explains why Calocurb is very safe, and its four to six-hour mode of action. The three primary use cases for Calocurb, and how it helps to reduce the side effects and costs associated with GLP-1 injections The importance of making lifestyle changes when transitioning off GLP-1 medications How Calocurb stimulates natural GLP-1 receptors, making it easier to manage food cravings during intermittent fasting Sarah shares how Calocurb helped her manage her love-hate relationship with food. How to take Calocurb for optimal effectiveness Sarah outlines Calocurb’s four core values. How Calocurb differs from other supplements Foods that help to reinforce the satiety mechanism You can use code CYNTHIA10 for 10% off an order on ⁠calocurb.com⁠. Connect with Cynthia Thurlow Follow on X, Instagram & LinkedIn Check out Cynthia’s website Submit your questions to [email protected] Connect with Sarah Kennedy You can use code CYNTHIA10 for 10% off an order on ⁠⁠calocurb.com⁠⁠. Research Articles: Gastrointestinal delivery of bitter hop extract reduces appetite and food cravings in healthy adult women undergoing acute fasting New Zealand Bitter Hops Extract Reduces Hunger During a 24h Water Only Fast Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.